Key concept: the most common osteoporosis drug destroys metabolic health If you’ve been prescribed medication for osteoporosis, you’re likely familiar with bisphosphonates like Fosamax (alendronate) or Reclast (zoledronic acid). These medications are highly effective at reducing fracture risk, but emerging research suggests they may have an important metabolic side effect that deserves your attention: depletion […]